1. The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats
   Vesna Jaćević et al, 2018, IJMS CrossRef
2. A Noninvasive Imaging Toolbox Indicates Limited Therapeutic Potential of Conditionally Activated Macrophages in a Mouse Model of Multiple Organ Dysfunction
   Jack Sharkey et al, 2019, Stem Cells International CrossRef
3. Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal
   Shasha Song et al, 2019, Front. Pharmacol. CrossRef
4. Monosialoganglioside GM1 reduces toxicity of Ptx and increase anti-metastasic effect in a murine mammary cancer model
   Victoria Leonhard et al, 2020, Sci Rep CrossRef
5. PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway
   Zhihong Lu et al, 2021, Cytotechnology CrossRef
6. Preventive and therapeutic use of herbal compounds against doxorubicin induced hepatotoxicity: a comprehensive review
   Faezeh Mahmoudi et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
7. Anti-TNFR2 Antibody-Conjugated PLGA Nanoparticles for Targeted Delivery of Adriamycin in Mouse Colon Cancer
   Ping Li et al, 2024, Research CrossRef